A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...

"Hearst Magazines and AOL may earn commission or revenue on some items through these links." As we age, so do our cells. But some scientists are wondering if we actually need to accept this inevitable ...

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...